In today’s biotechnology and healthcare sectors, the demand for ‘effectiveness’ among consumers and businesses is reaching unprecedented heights. The era of merely adding concepts is over; true ingredient innovation must be rooted in a solid scientific foundation.

As a global pioneer in life sciences, we are committed to transforming cutting-edge laboratory discoveries into high-quality raw materials for commercial applications. Through in-depth academic collaboration with Professor Gregg L. Semenza, a Nobel Laureate in Physiology or Medicine, we have unravelled the underlying mechanisms by which cells perceive and adapt to oxygen supply, and have applied these insights to the development of new raw materials. To date, the Group has been granted a total of 15 international PCT patents.

To precisely empower our global clients, we have established three flagship business divisions: NVTIA, specialising in plant extraction and the transformation of new ingredients; BCLC, a premium anti-ageing brand originating from cutting-edge Swiss laboratories; and Balimont, a probiotic brand developed in collaboration with the European Institute of Life Sciences in the UK. We do not merely supply ingredients; we provide scientific solutions that are set to change the rules of the game within the industry.